Navigation Links
Labopharm Reports Results for Second Quarter Fiscal 2009
Date:8/7/2009
---------------- REVENUE Product sales 4,827 3,859 8,629 6,017 Licensing 1,318 1,064 2,473 2,125 Royalties 124 - 124 - ------------------------------------------------------------------------- 6,269 4,923 11,226 8,142 ------------------------------------------------------------------------- EXPENSES Cost of goods sold (excluding depreciation and amortization) 2,604 1,683 3,997 2,634 Research and development expenses, net 2,861 6,306 6,888 11,997 Selling, general and administrative expenses 6,310 6,209 13,034 11,116 Financial expenses 983 709 1,997 1,420 Impairment loss on long-term investment - - - 691 Depreciation and amortization 453 490 916 975 Interest income (107) (551) (294) (1,203) Foreign exchange gain (1,961) (20) (2,464) (292) ------------------------------------------------------------------------- 11,143 14,826 24,074 27,338 ------------------------------------------------------------------------- Loss before income taxes (4,874) (9,903) (12,848) (19,196) Provision for income taxes Current - 350 - 800 ------------------------------------------------------------------------- Net loss for the period (4,874) (10,253) (12,848) (19,996) --------------------------------------------------------
'/>"/>
| SOURCE Labopharm Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
2. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
3. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
4. Labopharm amends debt facility agreement with Hercules
5. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Labopharm announces details for first quarter results conference call and annual meeting
8. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
9. Labopharm to present at Cowen 29th Annual Health Care Conference
10. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
11. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
Post Your Comments:
(Date:5/20/2013)... WEDI, the leading authority on the ... healthcare information, announced today at the WEDI 22nd Annual ... State Collaborative Initiative. The new initiative will bring together ... increase efficiencies and reduce the significant time and costs ... new initiative is to help facilitate inter-state communication around ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 VHA ... the leader in automated, provider-led population health improvement, ... to effect change and successfully pursue population health ... services and technology to accelerate the transition to ... VHA IMPERATIVTM performance improvement suite of services, the ...
(Date:5/20/2013)... The Multiple System Atrophy Coalition (formerly the SDS/MSA ... Multiple System Atrophy (MSA) Research Grant Program . ... grass roots fundraising has grown and enabled the 501(c)3 ... now include education, advocacy and research funding initiatives. ... Coalition go directly into a dedicated MSA Research Fund, ...
(Date:5/20/2013)... Online education provides the convenience, flexibility and cost-saving ... According to the American Heart Association, 27% of ... to eLearning due to changing economic conditions. The ... budgets, but it is also proven to enhance ... higher retention of content is probable, given the ...
(Date:5/20/2013)... The 17th ECCO 38th ESMO 32nd ESTRO ... Amsterdam, The Netherlands ( http://www.rai.nl ), from Friday 17 ... fide journalists is free. , The congress will build ... Organisation), ESMO (European Society for Medical Oncology) and ESTRO ... is the only cancer congress in Europe to offer ...
Breaking Medicine News(10 mins):Health News:WEDI Launches New ICD-10 State Collaborative Initiative to Increase Efficiencies and Reduce Compliance Time and Costs 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2Health News:Media registration for the European Cancer Congress 2[0] WEDI Launches New ICD-10 State Collaborative Initiative to Increase Efficiencies and Reduce Compliance Time and Costs[0] VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings[0] Multiple System Atrophy (MSA) Research Grant Program Announced[0] Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses[0] Media registration for the European Cancer Congress
... Rochelle, NY -- The current issue of Medical ... Liebert, Inc., explores how the U.S. military is incorporating ... military personnel serving in the war zones and the ... issue is available online at http://www.liebertpub.com/acu . ...
... 4, 2012 As the pharmaceutical industry continues to ... protecting patients from counterfeit medicines, as well as the ... mounted. In an effort to encourage comprehensive public standards ... is proposing a set of recommended best practices that ...
... used extensively in Chinese traditional medicine that kill ... the leading causes of tooth loss in children and adults. ... , they say that these substances could have a role ... Stefan Gafner and colleagues explain that the dried root ...
... Weight loss surgery is not a cure for type 2 ... a new study published in the British Journal of ... to 80 per cent of diabetes patients have been cured ... that only 41 per cent of patients achieve remission using ...
... -- Arrogant people are less likely than humble people to ... Although personal factors (such as previous time commitments and ... how many people are watching) come into play, humility is ... helping hand, according to the study published online Jan. 2 ...
... a study that investigates the challenges of disseminating clinical research ... have found that fewer than half of a sample of ... Health (NIH) were published within 30 months of completing the ... issue of the British Medical Journal , which focuses ...
Cached Medicine News:Health News:Proposed standard offers best practices to help ensure pharmaceutical supply chain integrity 2Health News:Proposed standard offers best practices to help ensure pharmaceutical supply chain integrity 3Health News:Proposed standard offers best practices to help ensure pharmaceutical supply chain integrity 4Health News:Scientists reassess weight loss surgery for type 2 diabetes 2Health News:Need Help? Seek Out the Humble 2Health News:Many NIH-funded clinical trials go unpublished over 2 years after completion 2Use of acupuncture in the US military highlighted in special issue of Medical AcupunctureProposed standard offers best practices to help ensure pharmaceutical supply chain integrityDried licorice root fights the bacteria that cause tooth decay and gum diseaseScientists reassess weight loss surgery for type 2 diabetesNeed Help? Seek Out the HumbleMany NIH-funded clinical trials go unpublished over 2 years after completion
(Date:5/19/2013)... , May 19, 2013 The non-surgical ... temperature radiofrequency (RF) energy is effective in control ... reduces the need for medication 10 years post-procedure, ... today at the Digestive Disease Week (DDW) meeting ... . "The sustained improvement ...
(Date:5/18/2013)... NEW YORK , May 18, 2013 /PRNewswire/ ... securities law firm, is investigating potential securities fraud ... (NASDAQ: AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ... the Company and its executives violated federal securities ... regarding the Company,s Phase III drug trials for ...
(Date:5/17/2013)... , May 17, 2013 Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, healthcare and to first responders ... its financial results for the fiscal 2013 fourth quarter ... 21, 2013 at stock market close and will conduct ... p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2[0] Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy[0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm[0] Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call
... theVisualMD, www.thevisualmd.com , the world,s leading health visualization resource ... Visual Rules of Wellness. Quest Diagnostics (NYSE: DGX ... services, is the official sponsor of the initiative,s first rule ... of Wellness aim to bring readers a new understanding of ...
... 3, 2012 GP Strategies Corporation (NYSE: ... of sales and technical training, e-Learning solutions, management consulting ... L.P. ("Sagard Capital") has agreed to purchase 350,000 shares ... The closing of the transaction is subject to customary ...
Cached Medicine Technology:theVisualMD Launches a Revolutionary New Visual Path to Wellness 2theVisualMD Launches a Revolutionary New Visual Path to Wellness 3theVisualMD Launches a Revolutionary New Visual Path to Wellness 4Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 2Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 3... is an automated microplate analyzer ... microplate techniques. Open architecture design ... many manufacturers' microplate assays and ... R.I.A. and I.F.A. methods as ...
... MAP D-Type can combine a number ... 180 microplates on a simple to ... instrument is a multifunctional stand-alone device ... larger robotic systems. Custom and standard ...
... provides a fast, accurate assessment of,patient ... patented,state-of-the-art optics yield accurate measurements of ... total hemoglobin. When,used in combination with ... gives a comprehensive and complete assessment ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |